Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0150 (-13.04%)
Jun 10, 2026, 9:39 AM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 32.67 million as of June 10, 2026. Its market cap has increased by 791.51% in one year.
Market Cap
32.67M
Enterprise Value
29.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 32.67M, an increase of 87.63%. That is a compound annual growth rate of 9.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 32.67M | 169.42% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 56.55M |
| NurExone Biologic | 54.31M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 38.77M |
| Microbix Biosystems | 38.57M |
| Defence Therapeutics | 37.89M |
| BriaCell Therapeutics | 36.80M |
| Resverlogix | 34.38M |